Search clinical trials for: Toca FC

Total 329 results

Tocagen Inc.

Completed

Study of a Retroviral Replicating Vector Combined With a Prodrug to Treat Patients Undergoing Surgery for a Recurrent Malignant Brain Tumor

Glioblastoma Multiforme | Anaplastic Oligoastrocytoma | Anaplastic Astrocytoma | Anaplastic Oligodendroglioma

United States
Tocagen Inc.

Completed

Study of a Retroviral Replicating Vector Given Intravenously to Patients Undergoing Surgery for Recurrent Brain Tumor

Glioblastoma Multiforme | Anaplastic Oligoastrocytoma | Anaplastic Astrocytoma | Anaplastic Oligodendroglioma

United States
Tocagen Inc.

Completed

A Study of a Retroviral Replicating Vector Combined With a Prodrug Administered to Patients With Recurrent Malignant Glioma

Glioblastoma | Anaplastic Oligoastrocytoma | Anaplastic Astrocytoma | Anaplastic Oligodendroglioma

United States
Tocagen Inc.

Terminated

A Continuation Protocol for Patients Previously Enrolled in a Study of Toca 511

Astrocytoma | Glioblastoma Multiforme | Gliomas, Malignant

United States
Tocagen Inc.

Withdrawn

A Study of the Safety of Toca 511, a Retroviral Replicating Vector, Combined With Toca FC in Subjects With Newly Diagnosed High Grade Glioma Receiving Standard of Care (Toca7)

Newly Diagnosed High Grade Glioma (HGG)
Tocagen Inc.

Terminated

A Study of Toca 511, a Retroviral Replicating Vector, Combined With Toca FC in Patients With Solid Tumors or Lymphoma (Toca 6)

Melanoma | Sarcoma | Lymphoma | Head and Neck Cancer | Colorectal Cancer | Pancreatic Cancer | Ovarian Cancer | Non-Small Cell Lung Cancer | Bladder Cancer | Triple Negative Breast Cancer | IDH1 Mutated Solid Tumors | IDH1 Mutated or MGMT Methylated Recurrent HGG (Not Recruiting)

United States
Tocagen Inc.

Withdrawn

A Study of Toca 511 & Toca FC in Patients With Recurrent High Grade Non-Muscle Invasive Bladder Cancer (Toca 8)

Bladder Cancer
Tocagen Inc.

Terminated

The Toca 5 Trial: Toca 511 & Toca FC Versus Standard of Care in Patients With Recurrent High Grade Glioma (Toca5)

Glioblastoma Multiforme | Anaplastic Astrocytoma

United States, Korea, Republic of, Canada, Israel
Shandong University

Recruiting

FIT Combining FC for Predicting MH and Histology Remission in UC

Ulcerative Colitis | Mucosal Healing | Histology Remission | Fecal Calprotetin | FIT

China
Westat
Children's Bureau - Administration for Children and Families

Completed

Nevada Initiative to Reduce Long-Term Foster Care

In Foster Care | At Risk for Foster
Rabin Medical Center
PulseNmore

Recruiting

The Use of PulseNmore FC Device in Patients Undergoing IVF Treatment A Study to Evaluate the Safety and the Efficacy

Women Undergoing Fertility Treatments

Israel
Biomed Research & Technologies, Inc.

Completed

A Study of BRT-FC-83C for the Treatment of Atopic Dermatitis

Atopic Dermatitis

United States
Hospital Universitari Vall d'Hebron Research Institute

Unknown

Transbronchial Biopsies With Cryoprobe in Patients With Lung Transplantation.

Lung Transplant Rejection

Spain
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.

Recruiting

Safety and Efficacy of IMM01 Plus Tislelizumab in Patients With Advanced Solid Tumors and Lymphomas

Solid Tumor | Classic Hodgkin Lymphoma

China
NRG Oncology
National Cancer Institute (NCI)

Withdrawn

Testing the Addition of an Anti-cancer Viral Gene Therapy, Toca 511/Toca FC, to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed Glioblastoma

Glioblastoma | Anaplastic Astrocytoma | Oligodendroglioma | Supratentorial Glioblastoma
Bioverativ Therapeutics Inc.
Swedish Orphan Biovitrum

Terminated

Fc factOrs and Real-World hemophiliA Patient-ReporteD Outcomes (FORWARD)

Hemophilia A | Hemophilia B

United States
AryoGen Pharmed Co.

Completed

rFVIII-Fc (Produced by AryoGen Pharmed Co.) Pharmacokinetic Study

Severe Hemophilia A

Iran, Islamic Republic of
AdvanceCor GmbH
Procorde GmbH

Completed

Safety, Pharmacokinetic and -Dynamic Study of PR-15, an Inhibitor of Platelet Adhesion (PR-15/01)

Myocardial Infarction | Stroke | Thrombosis | Acute Coronary Syndrome

Germany
University of British Columbia

Recruiting

Pro-active Fecal Calprotectin Monitoring PROMOTE-UC

Ulcerative Colitis

Canada
Protalix

Completed

Study to Evaluate the Safety and Pharmacokinetics of Oral OPRX-106 (TNFR-Fc Fusion Protein) in Healthy Volunteers

Human Volunteer

Israel
Chinese University of Hong Kong

Recruiting

Thumb Ossification Composite Index (TOCI) to Predict Skeletal Maturity and Curve Progression in AIS (TOCI)

Bone Diseases | Scoliosis; Adolescence | Bone Growth Abnormal

Hong Kong
Andreas Monsch

Completed

Normative Values for the German Version of the Montreal Cognitive Assessment (MoCA) (MoCA-Norm)

Cognitive Impairment | Dementia | Cognitive Change | Cognition Disorders | Cognitive Decline | Dementia, Alzheimer Type | Cognitive Deterioration | Cognitive Symptom | Cognition Disorders in Old Age | Dementia Alzheimers | Dementia of Alzheimer Type | Cognitive Impairment, Mild | Dementia, Mild | Cognitive Abnormality
University of Ottawa

Recruiting

It's Time to Address Fear of Cancer Recurrence in Family Caregivers: Online Version of the Fear Of Recurrence Therapy (FC-FORT)

Cancer | CBT | Caregiver | Fear Cancer

Canada
Dr Abdurrahman Yurtaslan Ankara Oncology Training...

Completed

Correlation of Preoperative Anxiety With Early Postoperative Cognitive Dysfunction in Breast Cancer Patients

Postoperative Cognitive Dysfunction | Preoperative Anxiety

Turkey
Mansoura University Hospital

Completed

Cognitive Impairment and Neuropsychiatric Manifestations of Neurobrucellosis

Brucellosis

Egypt
Inozyme Pharma

Recruiting

The ENERGY Study: Evaluation of Safety and Tolerability of INZ-701 in Infants With ENPP1 Deficiency (ENERGY)

Generalized Arterial Calcification of Infancy | Autosomal Recessive Hypophosphatemic Rickets | Ectonucleotide Pyrophosphatase/phosphodiesterase1 Deficiency

United States
Inozyme Pharma

Recruiting

Evaluation of Safety, Tolerability, and Efficacy of INZ-701 in Adults With ENPP1 Deficiency

Generalized Arterial Calcification of Infancy | Autosomal Recessive Hypophosphatemic Rickets | Ectonucleotide Pyrophosphatase/phosphodiesterase1 Deficiency

United States, United Kingdom, Canada, France, Germany
Inozyme Pharma
IQVIA Biotech

Active, not recruiting

Evaluation of Safety, Tolerability, and Efficacy of INZ-701 in Adults With ABCC6 Deficiency Causing PXE

Pseudoxanthoma Elasticum | Generalized Arterial Calcification of Infancy | ATP-Binding Cassette Subfamily C Member 6 Deficiency

United States, United Kingdom
Inhibrx, Inc.

Completed

Phase 1 Study to Assess the Safety, PK and PD of INBRX-101 in Adults With Alpha-1 Antitrypsin Deficiency (rhAAT-Fc)

Alpha-1 Antitrypsin Deficiency | AATD

United States, New Zealand, United Kingdom
Rijnstate Hospital
St. Antonius Hospital; BovenIJ Hospital; OLVG

Completed

MOCA Versus RFA in the Treatment of Primary Great Saphenous Varicose Veins (MARADONA)

Greater Saphenous Vein Injury

Netherlands
Zhejiang Hisun Pharmaceutical Co. Ltd.

Unknown

Efficacy and Safety Study of Anbainuo in Chinese Patients With RA/AS in the Real World

Rheumatoid Arthritis | Ankylosing Spondylitis
University Hospital of Ferrara

Completed

Task-oriented Circuit Training Combined With Cerebellar tDCS in Multiple Sclerosis Subjects

Multiple Sclerosis Subjects

Italy
University Hospital of Ferrara

Completed

Efficacy of TOCT and (tDCS) for Gait Improvement in Patients With Chronic Stroke

Stroke

Italy
The Hong Kong Polytechnic University

Not yet recruiting

Flipped Classroom Approach in Continuous Ambulatory Peritoneal Dialysis Training (FCCAPD)

Chronic Kidney Disease

Hong Kong
Catholic University of the Sacred Heart

Completed

Self-expandable, Fully Covered Metal Stents in Biliary Strictures Due to Chronic Pancreatitis

Chronic Pancreatitis | Benign Biliary Strictures
University of Wisconsin, Madison

Completed

Thoracic OncoGeriatric Assessment (TOGA) Trials (TOGA)

Lung Neoplasms | Thoracic Neoplasms | Thymus Neoplasms | Pleural Neoplasms | Esophagus Neoplasms

United States
Clalit Health Services

Unknown

MoCa Test for the Early Detection of Mild Cognitive Impairment During Annual Assessment of Young Adults With Diabetes and in a Control Group Without Diabetes

Diabetes Mellitus Type 2 | Mild Cognitive Impairment | Diabetes Mellitus Type 1

Israel
FBD Biologics Limited

Recruiting

A Safety and Efficacy Study of HCB101, Fc-fusion Protein Targeting SIRPα-CD47 Pathway, in Solid or Hematological Tumors

Advanced Solid Tumor | Refractory Non-Hodgkin Lymphoma

Taiwan, United States
Bioverativ, a Sanofi company
Swedish Orphan Biovitrum

Completed

Study to Determine the Safety and Efficacy of rFIXFc in Previously Untreated Males With Severe Hemophilia B (PUPs B-LONG)

Hemophilia B

United States, Italy, Ireland, New Zealand, United Kingdom, Australia, Netherlands, Denmark, Poland, Sweden, France
MoCA Clinic and Institute

Active, not recruiting

Validation of a Digital Self-Administered Cognitive Screening Tool: MoCA-XpressO (MoCA)

Cognitive Impairment | Cognitive Change | Cognitive Deficit | Assessment, Self

Canada
University Hospital Tuebingen

Completed

Studying Cognition in SPG4

Cognitive Impairment | Hereditary Spastic Paraplegia

Germany
Satiety, Inc.

Unknown

Transoral Gastroplasty for the Treatment of Morbid Obesity (TOGA®)

Obesity

United States, Belgium
Bioverativ Therapeutics Inc.
Swedish Orphan Biovitrum

Completed

Pharmacokinetics and Safety of rFVIIIFc Manufactured at 15,000 L (15K) Scale (Elevate)

Severe Hemophilia A

United States, Australia, New Zealand
Bioverativ Therapeutics Inc.

Completed

Long-Term Safety and Efficacy of rFIXFc in the Prevention and Treatment of Bleeding Episodes in Previously Treated Participants With Hemophilia B (B-YOND)

Severe Hemophilia B

United States, Italy, Belgium, Australia, Brazil, Hong Kong, India, Ireland, Japan, South Africa, United Kingdom, Netherlands, Sweden, Canada, Poland, China, France, Germany
NYU Langone Health

Recruiting

Modulating Movement Intention Via Cortical Stimulation

Seizures | Seizure Disorder | Psychogenic Movement Disorder

United States
Haukeland University Hospital
Western Norway University of Applied Sciences

Recruiting

Edinburgh Cognitive and Behavioural Amyotrophic Lateral Sclerosis Screen in Norway: A Validation Study

Cognitive Impairment | Amyotrophic Lateral Sclerosis

Norway
Bioverativ, a Sanofi company
Swedish Orphan Biovitrum

Completed

An Open Label Study to Determine the Safety and Efficacy of Replacement Factor VIII Protein (Known as rFVIIIFc) in Previously Untreated Males With Severe Hemophilia A

Hemophilia A

United States, France, Italy, Spain, Netherlands, United Kingdom, Ireland, New Zealand, Poland, Australia, Germany, Brazil, Sweden, Canada
Bioverativ Therapeutics Inc.

Completed

Pharmacokinetics of rFVIIIFc at Two Vial Strengths

Severe Hemophilia A

United States, United Kingdom, Australia
Emory University
Bioverativ Therapeutics Inc.

Completed

Extended Half Life Factor (EHF) Products For Heavy Menstrual Bleeding in Hemophilia Carriers

Hemophilia | Menstrual Flow Excessive

United States
Hengenix Biotech Inc

Completed

Evaluate the Safety, Tolerability, Pharmacodynamics, Pharmacokinetics, and Immunogenicity of HLX71 (Recombinant Human Angiotensin-converting Enzyme 2-Fc Fusion Protein for COVID-19) in Healthy Adult Subjects

COVID 19

United States

Search clinical trials for: Toca FC

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mali

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations